Comparative Pharmacology
Head-to-head clinical analysis: DIALYTE CONCENTRATE W DEXTROSE 50 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 3 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIALYTE CONCENTRATE W DEXTROSE 50 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 3 5 IN PLASTIC CONTAINER.
DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER vs DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Provides dextrose as a caloric source and electrolyte replacement in peritoneal dialysis. Dextrose is metabolized to carbon dioxide and water, generating ATP. The high osmolality of the solution promotes ultrafiltration of fluid across the peritoneal membrane, facilitating removal of uremic toxins and excess fluid.
Dianeal PD-2 with Dextrose 3.5% is a peritoneal dialysis solution. Dextrose provides an osmotic gradient that facilitates the removal of uremic toxins and excess fluid from the blood across the peritoneal membrane into the dialysate. The solution also contains electrolytes to correct imbalances.
Not applicable; dialysate concentrate is used in hemodialysis machines, not administered directly to patients. Dextrose concentration in final dialysate is typically 1.5-2.5 g/dL depending on prescription.
2 to 3 liters intraperitoneally, 4 exchanges daily, with dwell times of 4-6 hours for CAPD; or 2 to 2.5 liters intraperitoneally, cycler-assisted, 3-5 cycles nightly for APD. Dextrose 3.5% solution used based on ultrafiltration needs.
None Documented
None Documented
Not applicable as a fixed half-life; glucose has a plasma elimination half-life of approximately 15-20 minutes, but this is concentration-dependent. Dialysis solutions are not administered as a single intravenous dose; the components are continuously infused.
The elimination half-life of dextrose from the systemic circulation is approximately 3.5-4.5 hours after intraperitoneal administration. Clinically, this reflects the rate of glucose absorption and metabolism, which can be altered in patients with impaired glucose tolerance or diabetes.
Renal excretion of glucose and electrolytes; glucose is completely reabsorbed or metabolized, while electrolytes are excreted proportionally to serum levels and renal function. 100% renal elimination of administered electrolytes.
Peritoneal dialysis (PD) with 3.5% dextrose solution results in elimination of excess fluid and solutes via the peritoneal membrane. Dextrose is absorbed systemically and metabolized. The primary route of elimination of dialytic waste products (e.g., urea, creatinine) is via the peritoneal fluid itself, which is drained. Less than 1% of dextrose is excreted unchanged in urine. Biliary/fecal excretion is negligible.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution